{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:19:11Z","timestamp":1789067951512,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372315"],"award-info":[{"award-number":["82372315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08409-w","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:07:23Z","timestamp":1751958443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Single-cell analysis links DCUN1D5 to immune remodeling and cisplatin resistance in recurrent osteosarcoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Xin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woding","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1622-7547","authenticated-orcid":false,"given":"Qiangqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7604-3684","authenticated-orcid":false,"given":"Jianbin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"8409_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.34133\/research.0530","volume":"7","author":"N Tang","year":"2024","unstructured":"Tang, N. et al. Single-Cell Spatial-Temporal Analysis of ZNF451 in Mediating Drug Resistance and CD8<SUP>+<\/SUP> T Cell Dysfunction. Research 7, 23 (2024).","journal-title":"Research"},{"key":"8409_CR2","first-page":"e2309755","volume":"11","author":"J Qiu","year":"2024","unstructured":"Qiu, J. et al. Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors. Adv. Sci. (Weinh.) 11, e2309755 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"8409_CR3","first-page":"1802012","volume":"6","author":"L Yang","year":"2019","unstructured":"Yang, L. et al. Synergetic Functional Nanocomposites Enhance Immunotherapy in Solid Tumors by Remodeling the Immunoenvironment. Adv. Sci. (Weinh.) 6, 1802012 (2019).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"8409_CR4","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1021\/acsnano.7b08148","volume":"12","author":"H Jin","year":"2018","unstructured":"Jin, H. et al. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel. ACS Nano 12, 3295\u20133310 (2018).","journal-title":"ACS Nano"},{"key":"8409_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.tips.2024.09.006","volume":"45","author":"JT Low","year":"2024","unstructured":"Low, J. T., Ho, P. C. & Matsushita, M. TAM-tastic: from resistance to resilience in cancer. Trends Pharm. Sci. 45, 953\u2013954 (2024).","journal-title":"Trends Pharm. Sci."},{"key":"8409_CR6","doi-asserted-by":"publisher","first-page":"156291","DOI":"10.1016\/j.phymed.2024.156291","volume":"136","author":"N Tang","year":"2024","unstructured":"Tang, N. et al. Decoding the role of SLC25A5 in osteosarcoma drug resistance and CD8+ T cell exhaustion: The therapeutic potential of phyllanthin. Phytomedicine 136, 156291\u2013156291 (2024).","journal-title":"Phytomedicine"},{"key":"8409_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2021.806189","volume":"12","author":"ZG Wu","year":"2022","unstructured":"Wu, Z. G. et al. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma. Front. Immunol. 12, 19 (2022).","journal-title":"Front. Immunol."},{"key":"8409_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-022-01596-8","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells. Mol. Cancer 21, 133 (2022).","journal-title":"Mol. Cancer"},{"key":"8409_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13045-022-01366-5","volume":"15","author":"K Beider","year":"2022","unstructured":"Beider, K. et al. CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression. J. Hematol. Oncol. 15, 144 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"8409_CR10","doi-asserted-by":"publisher","first-page":"27920","DOI":"10.1021\/acsami.1c06059","volume":"13","author":"X Wu","year":"2021","unstructured":"Wu, X. et al. A Targeted Erythrocyte Membrane-Encapsulated Drug-Delivery System with Anti-osteosarcoma and Anti-osteolytic Effects. ACS Appl. Mater. Interfaces 13, 27920\u201327933 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"8409_CR11","doi-asserted-by":"publisher","first-page":"e2110094","DOI":"10.1002\/adma.202110094","volume":"34","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z. et al. Versatile Polymer-Initiating Biomineralization for Tumor Blockade Therapy. Adv. Mater. 34, e2110094 (2022).","journal-title":"Adv. Mater."},{"key":"8409_CR12","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-13-3191","volume":"20","author":"A Lamora","year":"2014","unstructured":"Lamora, A. et al. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin. Cancer Res. 20, 5097\u20135112 (2014).","journal-title":"Clin. Cancer Res."},{"key":"8409_CR13","first-page":"292","volume":"12","author":"WB Liu","year":"2022","unstructured":"Liu, W. B. et al. A simple, universal and multifunctional template agent for personalized treatment of bone tumors. Bioact. Mater. 12, 292\u2013302 (2022).","journal-title":"Bioact. Mater."},{"key":"8409_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng, L., Meng, T., Chen, L., Wei, W. & Wang, P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct. Target Ther. 5, 11 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"8409_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","volume":"30","author":"SO Lim","year":"2016","unstructured":"Lim, S. O. et al. Deubiquitination and Stabilization of PD-L1 by CSN5. Cancer Cell 30, 925\u2013939 (2016).","journal-title":"Cancer Cell"},{"key":"8409_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29401-6","volume":"13","author":"W Xiong","year":"2022","unstructured":"Xiong, W. et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat. Commun. 13, 1700 (2022).","journal-title":"Nat. Commun."},{"key":"8409_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma, D. A., Chen, Z., Bullock, A. N. & Yamada, K. M. Ubiquitin ligases: guardians of mammalian development. Nat. Rev. Mol. Cell Biol. 23, 350\u2013367 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"8409_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13062-024-00481-2","volume":"19","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1\/PI3K\/AKT pathway. Biol. Direct 19, 42 (2024).","journal-title":"Biol. Direct"},{"key":"8409_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41598-024-84539-1","volume":"15","author":"S Zhao","year":"2025","unstructured":"Zhao, S. et al. DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma. Sci. Rep. 15, 403 (2025).","journal-title":"Sci. Rep."},{"key":"8409_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/1078-0432.CCR-13-1252","volume":"20","author":"CC Bommelj\u00e9","year":"2014","unstructured":"Bommelj\u00e9, C. C. et al. Oncogenic function of SCCRO5\/DCUN1D5 requires its Neddylation E3 activity and nuclear localization. Clin. Cancer Res. 20, 372\u2013381 (2014).","journal-title":"Clin. Cancer Res."},{"key":"8409_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 500, 1\u201310 (2021).","journal-title":"Cancer Lett."},{"key":"8409_CR22","first-page":"20","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X., Deng, Z. & Zhao, Q. Q. Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study. Front. Immunol. 13, 20 (2022).","journal-title":"Front. Immunol."},{"key":"8409_CR23","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1002\/slct.202001361","volume":"5","author":"AS Martins","year":"2020","unstructured":"Martins, A. S. et al. Cytotoxicity of Platinum and Palladium Chelates against Osteosarcoma. Chemistryselect 5, 5993\u20136000 (2020).","journal-title":"Chemistryselect"},{"key":"8409_CR24","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.cbi.2023.110685","volume":"384","author":"LM Balsa","year":"2023","unstructured":"Balsa, L. M. et al. Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models. Chem.-Biol. Interact. 384, 110685 (2023).","journal-title":"Chem.-Biol. Interact."},{"key":"8409_CR25","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","volume":"19","author":"J Niu","year":"2023","unstructured":"Niu, J. et al. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy 19, 1693\u20131710 (2023).","journal-title":"Autophagy"},{"key":"8409_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-9966-33-12","volume":"33","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J. Exp. Clin. Cancer Res.: CR 33, 12 (2014).","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"8409_CR27","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1016\/j.cell.2024.08.001","volume":"187","author":"JL Engel","year":"2024","unstructured":"Engel, J. L. et al. The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance. Cell 187, 6055\u20136070.e6022 (2024).","journal-title":"Cell"},{"key":"8409_CR28","doi-asserted-by":"publisher","first-page":"17079","DOI":"10.1073\/pnas.0806092105","volume":"105","author":"S Rottenberg","year":"2008","unstructured":"Rottenberg, S. et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc. Natl Acad. Sci. USA 105, 17079\u201317084 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8409_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2023.11.019","volume":"36","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma. Cell Metab. 36, 159\u2013175.e158 (2024).","journal-title":"Cell Metab."},{"key":"8409_CR30","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.drup.2022.100822","volume":"61","author":"M Pi","year":"2022","unstructured":"Pi, M. et al. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resist Updat 61, 100822 (2022).","journal-title":"Drug Resist Updat"},{"key":"8409_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin, P. et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J. Hematol. Oncol. 15, 97 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"8409_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-022-01234-2","volume":"15","author":"M Swamydas","year":"2022","unstructured":"Swamydas, M., Murphy, E. V., Ignatz-Hoover, J. J., Malek, E. & Driscoll, J. J. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. J. Hematol. Oncol. 15, 17 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"8409_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/2159-8290.CD-19-0154","volume":"9","author":"M Kansara","year":"2019","unstructured":"Kansara, M. et al. Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23. Cancer Discov. 9, 1511\u20131519 (2019).","journal-title":"Cancer Discov."},{"key":"8409_CR34","first-page":"221","volume":"17","author":"L Fu","year":"2022","unstructured":"Fu, L., Zhang, W., Zhou, X., Fu, J. & He, C. Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma. Bioact. Mater. 17, 221\u2013233 (2022).","journal-title":"Bioact. Mater."},{"key":"8409_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121407","volume":"282","author":"YX Ge","year":"2022","unstructured":"Ge, Y. X. et al. Enhancement of anti-PD-1\/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework. Biomaterials 282, 121407 (2022).","journal-title":"Biomaterials"},{"key":"8409_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/21645515.2023.2269788","volume":"19","author":"SW Ma","year":"2023","unstructured":"Ma, S. W., Wu, X., Wu, Z. G. & Zhao, Q. Q. Treatment-prognostication-adjustment a new therapeutic idea by analyzing T cell immune checkpoint in tumor microenvironment by algorithm: A bibliometric analysis. Hum. Vaccines Immunother. 19, 16 (2023).","journal-title":"Hum. Vaccines Immunother."},{"key":"8409_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20059-6","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat. Commun. 11, 6322 (2020).","journal-title":"Nat. Commun."},{"key":"8409_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana, R. D., Albores-Garc\u00eda, D., Cervantes-Villagrana, A. R. & Garc\u00eda-Acevez, S. J. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct. Target Ther. 5, 99 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"8409_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-021-01440-5","volume":"21","author":"G He","year":"2022","unstructured":"He, G. et al. Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol. Cancer 21, 19 (2022).","journal-title":"Mol. Cancer"},{"key":"8409_CR40","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri, R. & McAndrews, K. M. The role of extracellular vesicles in cancer. Cell 186, 1610\u20131626 (2023).","journal-title":"Cell"},{"key":"8409_CR41","doi-asserted-by":"publisher","first-page":"eabo5503","DOI":"10.1126\/science.abo5503","volume":"378","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Monitoring of cell-cell communication and contact history in mammals. Science 378, eabo5503 (2022).","journal-title":"Science"},{"key":"8409_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik, D. & Lathia, J. D. Cancer stem cell-immune cell crosstalk in tumour progression. Nat. Rev. Cancer 21, 526\u2013536 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"8409_CR43","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.7150\/thno.74053","volume":"12","author":"ZZ Lai","year":"2022","unstructured":"Lai, Z. Z. et al. Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure. Theranostics 12, 6527\u20136547 (2022).","journal-title":"Theranostics"},{"key":"8409_CR44","doi-asserted-by":"crossref","unstructured":"He, J. et al. Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss. J. Adv. Res. 53, 235\u2013248 (2023).","DOI":"10.1016\/j.jare.2023.01.003"},{"key":"8409_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jcis.2015.09.035","volume":"461","author":"C Torres-Rodr\u00edguez","year":"2016","unstructured":"Torres-Rodr\u00edguez, C. et al. Effects of bleaching on osteoclast activity and their modulation by osteostatin and fibroblast growth factor 2. J. Colloid Interface Sci. 461, 285\u2013291 (2016).","journal-title":"J. Colloid Interface Sci."},{"key":"8409_CR46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI40568","volume":"120","author":"EC Walker","year":"2010","unstructured":"Walker, E. C. et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J. Clin. Invest 120, 582\u2013592 (2010).","journal-title":"J. Clin. Invest"},{"key":"8409_CR47","first-page":"1813","volume":"35","author":"MH Khoso","year":"2022","unstructured":"Khoso, M. H. et al. Purification and extraction of fibroblast growth factor 21 (FGF-21) protein by sumo fusion in Escherichia coli. Pak. J. Pharm. Sci. 35, 1813\u20131818 (2022).","journal-title":"Pak. J. Pharm. Sci."},{"key":"8409_CR48","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1080\/10717544.2018.1482972","volume":"25","author":"J Niu","year":"2018","unstructured":"Niu, J. et al. Efficient treatment of Parkinson\u2019s disease using ultrasonography-guided rhFGF20 proteoliposomes. Drug Deliv. 25, 1560\u20131569 (2018).","journal-title":"Drug Deliv."},{"key":"8409_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tig.2007.09.002","volume":"23","author":"E Pauws","year":"2007","unstructured":"Pauws, E. & Stanier, P. FGF signalling and SUMO modification: new players in the aetiology of cleft lip and\/or palate. Trends Genet 23, 631\u2013640 (2007).","journal-title":"Trends Genet"},{"key":"8409_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-020-01269-4","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen, S. et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol. Cancer 19, 151 (2020).","journal-title":"Mol. Cancer"},{"key":"8409_CR51","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-020-14870-4","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma. Nat. Commun. 11, 1141 (2020).","journal-title":"Nat. Commun."},{"key":"8409_CR52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2011.07.040","volume":"146","author":"SA Williams","year":"2011","unstructured":"Williams, S. A. et al. USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell 146, 918\u2013930 (2011).","journal-title":"Cell"},{"key":"8409_CR53","first-page":"e2205483","volume":"10","author":"C Zeng","year":"2023","unstructured":"Zeng, C. et al. Targeting the Lysosomal Degradation of Rab22a-NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis. Adv. Sci. (Weinh.) 10, e2205483 (2023).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"8409_CR54","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1158\/0008-5472.CAN-15-0711","volume":"75","author":"J Cao","year":"2015","unstructured":"Cao, J. et al. Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells. Cancer Res. 75, 4839\u20134851 (2015).","journal-title":"Cancer Res."},{"key":"8409_CR55","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1038\/s41388-022-02446-z","volume":"41","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. CDK7\/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. Oncogene 41, 4524\u20134536 (2022).","journal-title":"Oncogene"},{"key":"8409_CR56","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.7150\/thno.51245","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics 11, 1473\u20131492 (2021).","journal-title":"Theranostics"},{"key":"8409_CR57","doi-asserted-by":"publisher","first-page":"107611","DOI":"10.1016\/j.pharmthera.2020.107611","volume":"214","author":"KH Lu","year":"2020","unstructured":"Lu, K. H., Lu, E. W., Lin, C. W., Yang, J. S. & Yang, S. F. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma. Pharm. Ther. 214, 107611 (2020).","journal-title":"Pharm. Ther."},{"key":"8409_CR58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/path.1953","volume":"209","author":"SG Sun","year":"2006","unstructured":"Sun, S. G., Lau, Y. S., Itonaga, I., Sabokbar, A. & Athanasou, N. A. Bone stromal cells in pagetic bone and Paget\u2019s sarcoma express RANKL and support human osteoclast formation. J. Pathol. 209, 114\u2013120 (2006).","journal-title":"J. Pathol."},{"key":"8409_CR59","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1002\/ctm2.652","volume":"12","author":"L Zheng","year":"2022","unstructured":"Zheng, L. et al. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-\u03baB\/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis. Clin. Transl. Med. 12, e652 (2022).","journal-title":"Clin. Transl. Med."},{"key":"8409_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm.2090","volume":"16","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat. Med 16, 214\u2013218 (2010).","journal-title":"Nat. Med"},{"key":"8409_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-017-0416-0","volume":"10","author":"H Hackl","year":"2017","unstructured":"Hackl, H., Astanina, K. & Wieser, R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J. Hematol. Oncol. 10, 51 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"8409_CR62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2014.11.013","volume":"41","author":"S Yang","year":"2014","unstructured":"Yang, S. et al. The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance. Immunity 41, 973\u2013987 (2014).","journal-title":"Immunity"},{"key":"8409_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-023-01398-5","volume":"16","author":"H Ming","year":"2023","unstructured":"Ming, H. et al. Protein degradation: expanding the toolbox to restrain cancer drug resistance. J. Hematol. Oncol. 16, 6 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"8409_CR64","doi-asserted-by":"publisher","first-page":"9390611","DOI":"10.1155\/2022\/9390611","volume":"2022","author":"H Zhan","year":"2022","unstructured":"Zhan, H. et al. Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS\/miR-579-3p\/MSH6 Axis. J. Oncol. 2022, 9390611 (2022).","journal-title":"J. Oncol."},{"key":"8409_CR65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2016.06.025","volume":"71","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells. Eur. Urol. 71, 8\u201312 (2017).","journal-title":"Eur. Urol."},{"key":"8409_CR66","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","volume":"608","author":"Y Ohta","year":"2022","unstructured":"Ohta, Y. et al. Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature 608, 784\u2013794 (2022).","journal-title":"Nature"},{"key":"8409_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S1470-2045(18)30742-3","volume":"20","author":"F Duffaud","year":"2019","unstructured":"Duffaud, F. et al. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol. 20, 120\u2013133 (2019).","journal-title":"Lancet Oncol."},{"key":"8409_CR68","doi-asserted-by":"publisher","first-page":"100631","DOI":"10.1016\/j.jbo.2024.100631","volume":"48","author":"Z Zhao","year":"2024","unstructured":"Zhao, Z. et al. Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX\/Bcl-2\/Caspase-9\/Caspase-3 pathway. J. Bone Oncol. 48, 100631 (2024).","journal-title":"J. Bone Oncol."},{"key":"8409_CR69","doi-asserted-by":"publisher","first-page":"e70248","DOI":"10.1002\/cam4.70248","volume":"13","author":"K Low","year":"2024","unstructured":"Low, K., Foulkes, P., Hills, F., Roberts, H. C. & Stordal, B. The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study. Cancer Med. 13, e70248 (2024).","journal-title":"Cancer Med."},{"key":"8409_CR70","doi-asserted-by":"publisher","first-page":"1378398","DOI":"10.3389\/fimmu.2024.1378398","volume":"15","author":"F Recine","year":"2024","unstructured":"Recine, F. et al. Clinical and translational implications of immunotherapy in sarcomas. Front Immunol. 15, 1378398 (2024).","journal-title":"Front Immunol."},{"key":"8409_CR71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","volume":"38","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell 38, 279\u2013296.e279 (2020).","journal-title":"Cancer Cell"},{"key":"8409_CR72","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic, D., Vucic, D. & Dikic, I. Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242\u20131253 (2014).","journal-title":"Nat. Med."},{"key":"8409_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04579-5","volume":"21","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis. J. Transl. Med. 21, 21 (2023).","journal-title":"J. Transl. Med."},{"key":"8409_CR74","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cell.2022.12.025","volume":"186","author":"K Oltion","year":"2023","unstructured":"Oltion, K. et al. An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes. Cell 186, 346\u2013362.e317 (2023).","journal-title":"Cell"},{"key":"8409_CR75","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","volume":"556","author":"KC Pao","year":"2018","unstructured":"Pao, K. C. et al. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. Nature 556, 381\u2013385 (2018).","journal-title":"Nature"},{"key":"8409_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0965-7","volume":"18","author":"S Maacha","year":"2019","unstructured":"Maacha, S. et al. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol. Cancer 18, 55 (2019).","journal-title":"Mol. Cancer"},{"key":"8409_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","volume":"20","author":"M Cully","year":"2021","unstructured":"Cully, M. Exosome-based candidates move into the clinic. Nat. Rev. Drug Discov. 20, 6\u20137 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8409_CR78","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","volume":"81","author":"A Geethadevi","year":"2021","unstructured":"Geethadevi, A. et al. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer Res. 81, 5336\u20135352 (2021).","journal-title":"Cancer Res."},{"key":"8409_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0292-x","volume":"12","author":"DS Skundric","year":"2015","unstructured":"Skundric, D. S., Cruikshank, W. W. & Drulovic, J. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis. J. Neuroinflammation 12, 78 (2015).","journal-title":"J. Neuroinflammation"},{"key":"8409_CR80","doi-asserted-by":"publisher","first-page":"45920","DOI":"10.1074\/jbc.M204196200","volume":"277","author":"S Alberti","year":"2002","unstructured":"Alberti, S. et al. Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome. J. Biol. Chem. 277, 45920\u201345927 (2002).","journal-title":"J. Biol. Chem."},{"key":"8409_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2012.01.025","volume":"46","author":"MD Cardamone","year":"2012","unstructured":"Cardamone, M. D. et al. A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2. Mol. Cell 46, 91\u2013104 (2012).","journal-title":"Mol. Cell"},{"key":"8409_CR82","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/biomedicines12081921","volume":"12","author":"V Giusti","year":"2024","unstructured":"Giusti, V. et al. Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research. Biomedicines 12, 1921 (2024).","journal-title":"Biomedicines"},{"key":"8409_CR83","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1158\/1078-0432.CCR-22-1471","volume":"28","author":"AR Cillo","year":"2022","unstructured":"Cillo, A. R. et al. Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks. Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res. 28, 4968\u20134982 (2022).","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"8409_CR84","doi-asserted-by":"publisher","first-page":"117693512211401","DOI":"10.1177\/11769351221140101","volume":"21","author":"E Rothzerg","year":"2022","unstructured":"Rothzerg, E. et al. Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues. Cancer Inf. 21, 11769351221140101 (2022).","journal-title":"Cancer Inf."},{"key":"8409_CR85","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/bioinformatics\/btab003","volume":"37","author":"J Alquicira-Hernandez","year":"2021","unstructured":"Alquicira-Hernandez, J. & Powell, J. E. Nebulosa recovers single-cell gene expression signals by kernel density estimation. Bioinformatics 37, 2485\u20132487 (2021).","journal-title":"Bioinformatics"},{"key":"8409_CR86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"8409_CR87","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"8409_CR88","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"8409_CR89","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","volume":"2117","author":"CB Steen","year":"2020","unstructured":"Steen, C. B., Liu, C. L., Alizadeh, A. A. & Newman, A. M. Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx. Methods Mol. Biol. 2117, 135\u2013157 (2020).","journal-title":"Methods Mol. Biol."},{"key":"8409_CR90","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform 22, bbab260 (2021).","journal-title":"Brief. Bioinform"},{"key":"8409_CR91","doi-asserted-by":"publisher","unstructured":"Xin, W., Tang, N., Zhao, Q. & Xiong, J. Spatiotemporal evolutionary process of osteosarcoma immune microenvironment remodeling and C1QBP-driven drug resistance deciphered through single-cell multi-dimensional analysis. Bioeng. Transl. Med. https:\/\/doi.org\/10.1002\/btm2.10654 (2024).","DOI":"10.1002\/btm2.10654"},{"key":"8409_CR92","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41388-021-01742-4","volume":"40","author":"H Li","year":"2021","unstructured":"Li, H. et al. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53. Oncogene 40, 2785\u20132802 (2021).","journal-title":"Oncogene"},{"key":"8409_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02057-0","volume":"23","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the \u201cSmart\u201d exosome nanoparticle therapy. Mol. Cancer 23, 144 (2024).","journal-title":"Mol. Cancer"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08409-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:17:00Z","timestamp":1752139020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08409-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8409"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08409-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The authors declare no competing interests. Figure\u00a0\n                      \n                      , Figure\u00a0\n                      \n                      and graphic abstract, was created with BioRender software (\n                      \n                      , accessed on 3 March 2023).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal care and experimental procedures were conducted in accordance with the guidelines and were approved by the Ethics Committee of the Department of Laboratory Animal Science, Central South University (Approval Number: CSU-2022-0664; Approval Date: October 10, 2022). We have complied with all relevant ethical regulations for animal use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1019"}}